Home LiteratureArticle Details
PMID: 2040056 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, P.H.S.

Inhaled nitric oxide. A selective pulmonary vasodilator reversing hypoxic pulmonary vasoconstriction.

Circulation ·Vol. 83 ·No. 6 ·1991-06-00 ·Pages 2038-47

Frostell C, Fratacci MD, Wain JC, Jones R, Zapol WM

Abstract

Background. The gas nitric oxide (NO) is an important endothelium-derived relaxing factor, inactivated by rapid combination with heme in hemoglobin. Methods and Results. Awake spontaneously breathing lambs inhaled 5-80 ppm NO with an acutely constricted pulmonary circulation due to either infusion of the stable thromboxane endoperoxide analogue U46619 or breathing a hypoxic gas mixture. Within 3 minutes after adding 40 ppm NO or more to inspired gas, pulmonary hypertension was reversed. Systemic vasodilation did not occur. Pulmonary hypertension resumed within 3-6 minutes of ceasing NO inhalation. During U46619 infusion pulmonary vasodilation was maintained up to 1 hour without tolerance. In the normal lamb, NO inhalation produced no hemodynamic changes. Breathing 80 ppm NO for 3 hours did not increase either methemoglobin or extravascular lung water levels nor modify lung histology compared with control lambs. Conclusions. Low dose inhaled NO (5-80 ppm) is a selective pulmonary vasodilator reversing both hypoxia- and thromboxane-induced pulmonary hypertension in the awake lamb [corrected].

MeSH Terms
Administration, Inhalation Animals Dose-Response Relationship, Drug Drug Tolerance Hypoxia/physiopathology Infusions, Intravenous Nitric Oxide/administration & dosage,pharmacology,poisoning Prostaglandin Endoperoxides, Synthetic/pharmacology Pulmonary Circulation/drug effects Sheep Time Factors Vasoconstriction/drug effects Vasodilator Agents/pharmacology
Chemicals
Prostaglandin Endoperoxides, Synthetic Vasodilator Agents Nitric Oxide
Authors & Affiliations
5 authors, click to expand affiliations / ORCID
Frostell C
Department of Anesthesia, Harvard Medical School, Massachusetts General Hospital, Boston.
Fratacci M D
Wain J C
Jones R
Zapol W M
Article Info
Journal
Circulation
Abbr.
Circulation
ISSN
0009-7322
Published
1991-06-00
Pages
2038-47
Language
English
Region
United States
NLM ID
0147763
Subset
IM
Grants
NHLBI NIH HHS · HL-42397 · United States
Corrections
ErratumIn
-
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com